These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 207383)

  • 1. Specific immunity to human papilloma virus (HPV) in patients with genital warts.
    Viac J; Staquet MJ; Miguet M; Chabanon M; Thivolet J
    Br J Vener Dis; 1978 Jun; 54(3):172-5. PubMed ID: 207383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo study of cell-mediated immunity in human warts. Preliminary results.
    Thivolet J; Hegazy MR; Viac J; Chardonnet Y
    Acta Derm Venereol; 1977; 57(4):317-9. PubMed ID: 70923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cell-mediated immunity to human papillomavirus type 1 (HPV-1) in human warts.
    Kienzler JL; Lemoine MT; Orth G; Jibard N; Blanc D; Laurent R; Agache P
    Br J Dermatol; 1983 Jun; 108(6):665-72. PubMed ID: 6305382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo controlled observer blind immunocytochemical and histologic study of epithelium adjacent to anogenital warts in patients treated with systemic interferon alpha in combination with cryotherapy or cryotherapy alone.
    Handley JM; Maw RD; Horner T; Lawther H; Walsh M; Dinsmore WW
    Genitourin Med; 1992 Apr; 68(2):100-5. PubMed ID: 1316307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hunan wart-virus antibodies in patients with genital and skin warts.
    Pyrhönen S
    Acta Derm Venereol; 1978; 58(5):427-32. PubMed ID: 82353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of cell mediated immunity in patients with genital warts of long duration.
    Avgerinou G; Georgala S; Theodoridis A; Vareltzdis A; Stratigos J
    Genitourin Med; 1986 Dec; 62(6):396-8. PubMed ID: 3817815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological events in regressing genital warts.
    Coleman N; Birley HD; Renton AM; Hanna NF; Ryait BK; Byrne M; Taylor-Robinson D; Stanley MA
    Am J Clin Pathol; 1994 Dec; 102(6):768-74. PubMed ID: 7801889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus.
    Viac J; Thivolet J; Chardonnet Y
    Br J Dermatol; 1977 Oct; 97(4):365-70. PubMed ID: 201265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus derived lymphocytes (T cells) in patients with genital warts.
    Mohanty KC; Roy RB
    Br J Vener Dis; 1984 Jun; 60(3):186-8. PubMed ID: 6610454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of human warts.
    Briggaman RA; Wheeler CE
    J Am Acad Dermatol; 1979 Oct; 1(4):297-304. PubMed ID: 229134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
    Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV).
    Viac J; Thivolet J; Hegazy MR; Chardonnet Y; Dambuyant C
    Clin Exp Immunol; 1977 Aug; 29(2):240-6. PubMed ID: 198169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to papillomavirus genus-antigens in women with genital warts.
    Portolani M; Mantovani G; Pietrosemoli P; Cermelli C; Boselli F
    Microbiologica; 1987 Jul; 10(3):271-9. PubMed ID: 3041183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating B and T lymphocyte subpopulations in patients with genital warts.
    Mohanty KC; Scott CS; Limbert HJ; Master PS
    Br J Clin Pract; 1987 Feb; 41(2):601-3. PubMed ID: 3499927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigenic relations between human papilloma viruses (HPV): experimental study in guinea-pigs (author's transl].
    Viac J; Staquet MJ; Thivolet J
    Ann Immunol (Paris); 1978; 129 C(4):559-70. PubMed ID: 80972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of HPV 1, 2 and 4 antibody prevalence in patients presenting for treatment with cutaneous warts to general practitioners in N. Ireland.
    Steele K; Shirodaria PV; Pfister H; Pollock B; Fuchs P; Merrett JD; Irwin WG; Simpson DI
    Epidemiol Infect; 1988 Dec; 101(3):537-46. PubMed ID: 2850937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of butchers' warts.
    Jabłońska S; Obalek S; Gołebiowska A; Favre M; Orth G
    Arch Dermatol Res; 1988; 280 Suppl():S24-8. PubMed ID: 2841908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1.
    Pfister H; zur Hausen H
    Med Microbiol Immunol; 1978 Nov; 166(1-4):13-9. PubMed ID: 214677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed immune reactivity in patients with genital warts].
    Scarpa C; Kokelj F
    Z Hautkr; 1985 Nov; 60(22):1809. PubMed ID: 4082698
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
    Haftek M; Jabłonska S; Orth G
    Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.